×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
概要
Participants will have the opportunity to interact with regulators including WHO, DCG(I), Indian MoH and Members of European Federation of Pharmaceutical Industries and Associations (EFPIA India Regulatory Network) and the Organisation of Pharmaceutical Producers of India (OPPI) on key regulatory topics including Orphan drug regulation, Clinical trial waiver, Accelerated regulatory pathway and Biological product/ Biosimilars registration in India.
プログラム委員会
-
Shekhar Natarajan Head-International Regulatory Strategy
Shire, United Kingdom, United Kingdom -
Bente Brunbakke Regional Manager-Gulf, India and Egypt,
Novo Nordisk A/S, Denmark -
Nagaraj Bannur Head-Regulatory Affairs and Patient Safety, India and Subcontinent
AstraZeneca Pharma India Limited, India -
Finny Liu, MSc, RPh APAC Regional Regulatory Policy Lead
Roche, Singapore -
Kum Cheun Wong, PharmD Head Asia Pacific Regulatory & Development Policy
Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Singapore -
Thean Soo Lo
Regulatory Affairs Management Consultant, Singapore
